Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 15, 2018
Pharmacy Choice - News - Front Page Healthcare News - October 15, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

9/15/18 - "Surgical Devices For Access To Surgical Sites" in Patent Application Approval Process (USPTO 20180235593)
By a News Reporter-Staff News Editor at Investment Weekly News A patent application by the inventors Seifert, Jody; Suh, Sean, filed on April 25, 2018, was made available online on August 23, 2018, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent application is assigned to Globus Medical I
9/15/18 - 2018 Dental Market: Global Size, Trends and Forecast Research Report: MarketReportsOnline.com adds "Global Dental Market (Restoratives, Implants, Orthodontics, Endodontic, Prosthetics & Equipment): Industry Analysis & Outlook (2018-2022)" report to i
Pune, India 09/14/2018 The report "Global Dental Market: Industry Analysis& Outlook" analyzes the development of this market, with specific focus on the US, European and Asian dental markets. Access Full Copy of Global Dental Market: Industry Analysis& Outlook spread across 115 Pages, Profiling 3 Companies and Supported with 76 charts is now
9/15/18 - AstraZeneca`s Lumoxiti gets FDA approval as hairy cell leukaemia treatment [Tehran Times (Iran)]
AstraZeneca and its global biologics research and development arm MedImmune announced on Friday that the US Food and Drug Administration has approved Lumoxiti for the treatment of adult patients with relapsed or refractory hairy cell leukaemia. The FTSE 100 drugmaker said the approval was for those patients who had received at least two prior syste
9/15/18 - BID-Plymouth opposes ballot question 1
Beth Israel Deaconess Hospital-Plymouth announced Sept. 12 its opposition to ballot question 1, which would mandate rigid nurse staffing ratios throughout the state. "Beth Israel Deaconess Hospital-Plymouth is nationally-recognized as a top hospital for patient safety and quality with a four-star rating from the Centers for Medicare and Medicaid a
9/15/18 - Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
INGELHEIM AM RHEIN, Germany, Sept. 13 Boehringer Ingelheim, a pharmaceutical company, issued the following news release:. Boehringer Ingelheim today announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies. Boehringer Ingelheim and ViraTherapeutics are.
9/15/18 - Celltrion Finalizes Clinical Trials for Remsima SC, Planning to File a Marketing Authorization Application to the EMA in H2
By a News Reporter-Staff News Editor at Marketing Weekly News Celltrion, Inc. announced that the company has completed Phase 3 clinical trial for' Remsima SC', the subcutaneous version of Remsima , the autoimmune disease therapeutic antibody biosimilar of infliximab, with the preparation for filing a Marketing Authorization Application to the E
9/15/18 - ChenMed and University of Miami Researchers Show High-Touch Care Improves Health Outcomes [Press TV (Iran)]
-Clinician researchers at ChenMed and the University of Miami today reported findings showing that Medicare-eligible seniors with Medicare Advantage insurance enjoy substantively better health outcomes when they benefit from high-intensity care that encourages frequent direct person-to-person interaction between patients and their primary...
9/15/18 - Colorectal Cancer Medicines Market to Reach $10.75bn in 2019, Predicts a New Visiongain Study
A new report by visiongain forecasts the world market for colorectal cancer drugs will reach $10.75 billion in 2019. Visiongain is a business information publisher and consultancy in London, UK. Sandra Wenas, a pharmaceutical industry analyst in visiongain, said: "The colorectal cancer drugs market will continue to expand at a steady pace, owing to
9/15/18 - Cooper University Health Care Research Team Instrumental in Clinical Trials of New Drug for Rare Genetic Disorder [T-break Tech (Middle East)]
Caroline Eggerding, MD, Division Head, Pediatric Neurology and Development led a research team at Cooper University Health Care which was instrumental in conducting clinical trials for a ground-breaking new drug approved earlier this year to treat Phenylketonuria, a rare genetic disorder. We are excited that medical science has found a new treatmen
9/15/18 - Dominican Hospital affected by mega-merger [Santa Cruz Sentinel, Calif.]
Sept. 15 SANTA CRUZ One of the terms of a mega-merger between Dominican Hospital parent Dignity Heath and Catholic Health Initiatives is status quo operation of Dominican Hospital, its emergency services, staff and facilities for five years post-agreement. Dominican Hospital, a 222- bed facility, reported $432 million in operating revenue in fi
9/15/18 - EDITORIAL: Congress can act to cut drug prices
Reports by the Federal Trade Commission and the Food and Drug Administration also show that generic competition saves billions of dollars annually, cutting the price of name-brand drugs by more than 85 percent. Patrick Leahy, D- Vt., and Chuck Grassley, R- Iowa, but the number of senators signing on as co-sponsors has been growing, including Sen.
9/15/18 - EpimAb Biotherapeutics Announces IND Filing for EMB01 in China and the US [Sudan Tribune]
EpimAb Biotherapeutics, an emerging Shanghai- based biopharmaceutical company specializing in bispecific antibodies, announced today that it has filed an IND for its most advanced therapeutic development candidate EMB01. The applications were simultaneously submitted to the U.S. Food and Drug Administration and the National Medical Products...
9/15/18 - FDA Approves Device for Treatment of Acute Coronary Artery Perforations
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:. The U.S. Food and Drug Administration today approved a device intended to treat acute coronary artery perforations, or tears in the blood vessels of the heart. "An acute coronary artery perforation is a rare, but potentially life-thre
9/15/18 - FDA Extends Acorda`s Inbrija NDA Review Period [T-break Tech (Middle East)]
Acorda Therapeutics, Inc. announced that the FDA has extended the Prescription Drug User Fee Act goal date for its review of the New Drug Application of Inbrija from October 5, 2018 to January 5, 2019. We look forward to continuing our constructive dialogue with FDA, said Ron Cohen, M.D., Acordas president and CEO. The FDA accepted Acordas NDA for
9/15/18 - FDA funds paediatric medical devices development [T-break Tech (Middle East)]
The US Food and Drug Administration has revealed plans to support the Pediatric Device Consortia programme aimed at the development, production and distribution of paediatric medical devices. Of the total funds, $1 m will be used for the Real World Evidence Demonstration Project. FDA commissioner Scott Gottlieb said: We know that developing product
9/15/18 - FDA grants fast track designation for HFpEF medication [Tehran Times (Iran)]
Ironwood Pharmaceuticals announced that praliciguat for the treatment of patients with HF with preserved ejection fraction has been granted fast track designation by the FDA. Praliciguat is an investigational soluble guanylate cyclase simulator that is administered orally, according to a press release from the company. An ever-increasing number of.
9/15/18 - FDA plans meeting on breast implant safety data FDA plans meeting to discuss safety data on breast implants
U.S. health regulators say they'll convene a public meeting of medical advisers next year to discuss new science on breast implant safety, including an independent analysis that suggests certain rare health problems might be more common with silicone gel implants. The Food and Drug Administration said it would hold the meeting even as its officials
9/15/18 - FDA proposes hospital subscriptions to medicines to fight deadly drug-resistant bacteria [Sudan Tribune]
Under the plan, hospitals would pay a flat rate for access to a certain number of doses for an antibiotic, FDA Commissioner Scott Gottlieb said. FDA is trying to tackle the lack of incentives for drug companies to create medicines by creating a more stable stream of funding from hospitals back to the companies. "Large pharmaceutical companies have
9/15/18 - First In Class Immunostimulating Anticancer Agent able to Directly Inhibit Tumor Signaling and Kill Tumor Cells, is in Clinical Trial for Glioblastoma and Melanoma Metastatic to the Brain [Tehran Times (Iran)]
In the ongoing challenge to combat the almost always deadly brain cancers, namely Glioblastoma and melanoma metastasized to the brain, the pharmaceutical company Moleculin Biotech, Inc., has initiated a Phase 1 clinical trial of a new first-in-class cancer drug candidate, a small molecule compound discovered by Prof. Waldemar Priebe at The Universi
9/15/18 - FIRST USFDA NOD FOR SUN'S HALOL AFTER WARNINGS
Sun Pharmaceutical Industries Limited has got approval from the US Food and Drug Administration for an abbreviated new drug application for treatment of glaucoma filed from its Halol plant in Gujarat.
9/15/18 - Global Gastrointestinal Endoscopy Devices Market Forecast to 2018-2023 : Medtronic, Stryker Corporation, Boston Scientific Corporation
Albany, NY 09/14/2018 A comprehensive research report created through extensive primary research and secondary research, the report aims to present the analysis of Global Gastrointestinal Endoscopy Devices Market By Product Type, By End User, By Region and By Country. According to Azoth Analytics research report "Global Gastrointestinal Endos
9/15/18 - Global Medical Implants Market Size and Forecast to 2025 : Abbott Laboratories, Edwards Lifesciences, Orthofix Holdings
Albany, NY 09/14/2018 This report studies the global market size of Medical Implants in key regions like North America, Europe, Asia Pacific, Central& South America and Middle East& Africa, focuses on the consumption of Medical Implants in these regions. This research report categorizes the global Medical Implants market by top players/brands
9/15/18 - Health officials applaud tougher FDA position on e-cigarettes [Enid News & Eagle, Okla.]
An FDA press release billed the operation as "the largest coordinated enforcement effort in the FDA' s history." In a Wednesday speech at FDA headquarters, FDA Commissioner Scott Gottlieb said there are "clear signs that youth use of electronic cigarettes has reached an epidemic proportion, and we must adjust certain aspects of our comprehensive st
9/15/18 - House Commerce Committee Issues Hearing Memo on Innovative, Value-Based Medicare
The Subcommittee on Health will hold a hearing on Thursday, September 13, 2018, at 1:15 p.m. in 2322 Rayburn House Office Building. *Michael Robertson, Chief Medical Officer, Covenant Health Partners;. *Michael Weinstein, President, Digestive Health Physicians Association;.
9/15/18 - Kiniksa Presents KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical need, today presented Phase 1 a/1b clinical data for KPL-716, an investigational fully-human monoclonal antibody that targets oncostatin M receptor beta, at.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415